JP2013504766A5 - - Google Patents

Download PDF

Info

Publication number
JP2013504766A5
JP2013504766A5 JP2012529334A JP2012529334A JP2013504766A5 JP 2013504766 A5 JP2013504766 A5 JP 2013504766A5 JP 2012529334 A JP2012529334 A JP 2012529334A JP 2012529334 A JP2012529334 A JP 2012529334A JP 2013504766 A5 JP2013504766 A5 JP 2013504766A5
Authority
JP
Japan
Prior art keywords
individual
ratio
soluble
synuclein
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012529334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504766A (ja
JP5778678B2 (ja
Filing date
Publication date
Priority claimed from GB0916264A external-priority patent/GB0916264D0/en
Priority claimed from GB201011045A external-priority patent/GB201011045D0/en
Application filed filed Critical
Priority claimed from PCT/GB2010/001723 external-priority patent/WO2011033252A1/en
Publication of JP2013504766A publication Critical patent/JP2013504766A/ja
Publication of JP2013504766A5 publication Critical patent/JP2013504766A5/ja
Application granted granted Critical
Publication of JP5778678B2 publication Critical patent/JP5778678B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012529334A 2009-09-16 2010-09-13 パーキンソン病の診断薬 Expired - Fee Related JP5778678B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0916264.5 2009-09-16
GB0916264A GB0916264D0 (en) 2009-09-16 2009-09-16 Diagnostic agent for parkinson's disease
GB201011045A GB201011045D0 (en) 2010-06-30 2010-06-30 Diagnostic agent for parkinsons disease
GB1011045.0 2010-06-30
PCT/GB2010/001723 WO2011033252A1 (en) 2009-09-16 2010-09-13 Diagnostic agent for parkinson's disease

Publications (3)

Publication Number Publication Date
JP2013504766A JP2013504766A (ja) 2013-02-07
JP2013504766A5 true JP2013504766A5 (enExample) 2013-10-31
JP5778678B2 JP5778678B2 (ja) 2015-09-16

Family

ID=42940401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529334A Expired - Fee Related JP5778678B2 (ja) 2009-09-16 2010-09-13 パーキンソン病の診断薬

Country Status (6)

Country Link
US (1) US20120190652A1 (enExample)
EP (1) EP2478375B1 (enExample)
JP (1) JP5778678B2 (enExample)
CA (1) CA2774274A1 (enExample)
ES (1) ES2541213T3 (enExample)
WO (1) WO2011033252A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201011420D0 (en) * 2010-07-06 2010-08-18 United Arab Emirates Universit Method for diagnosis
GB201411616D0 (en) * 2014-06-30 2014-08-13 Cambridge Entpr Ltd Diagnosis and treatment of neurodegenerative disorders
KR101860566B1 (ko) * 2016-12-06 2018-05-23 경희대학교 산학협력단 파킨슨병을 진단하기 위한 정보제공방법
KR102573778B1 (ko) 2017-02-17 2023-08-31 브리스톨-마이어스 스큅 컴퍼니 알파-시뉴클레인에 대한 항체 및 그의 용도
GB201803553D0 (en) 2018-03-06 2018-04-18 Univ Newcastle Detection of pathological protein aggregation
CN111024843B (zh) * 2019-12-18 2022-06-21 大连医科大学附属第一医院 用于诊断帕金森病的联合标志物及检测试剂盒
CN114047281B (zh) * 2022-01-04 2022-03-25 宝枫生物科技（北京）有限公司 帕金森病的生物标志物的组合及其应用
CN114019079B (zh) * 2022-01-04 2022-03-18 宝枫生物科技（北京）有限公司 诊断帕金森病的生物标志物及其应用
CN119310290A (zh) * 2024-11-28 2025-01-14 香港中文大学（深圳） 一种帕金森病的诊断标志物及其应用和杂聚体检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1095278B1 (en) * 1998-07-03 2005-12-07 Innogenetics N.V. Differential diagnosis of neurodegeneration
GB0203446D0 (en) * 2002-02-14 2002-04-03 Univ Lancaster Detection and/or monitoring of synuclein-related diseases
US20050202508A1 (en) * 2003-11-12 2005-09-15 Pasinetti Guilio M. Biomarker for Parkinson's disease
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
GB0716885D0 (en) * 2007-08-30 2007-10-10 United Arab Emirates Universit Diagnostic agent

Similar Documents

Publication Publication Date Title
JP2013504766A5 (enExample)
Shi et al. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
JP6430413B2 (ja) アルツハイマー病の診断のための方法と組成物
JP2009501333A5 (enExample)
Visanji et al. The systemic synuclein sampling study: toward a biomarker for Parkinson’s disease
JP2019530875A5 (enExample)
CN102933966A (zh) 阿尔茨海默病的新型诊断制剂
ES2706534T3 (es) Método para ayudar al diagnóstico diferencial del accidente cerebrovascular
US20130210667A1 (en) Biomarkers for Predicting Kidney and Glomerular Pathologies
JP6199880B2 (ja) 脳卒中の診断を補助するためのバイオマーカーに基づく方法およびバイオチップ
JP5847221B2 (ja) アルツハイマー病罹患リスクを検出する方法
Xu et al. An impedimetric assay of α-synuclein autoantibodies in early stage Parkinson's disease
JP2018536170A5 (enExample)
WO2009133197A3 (en) Levels of april in serum and use in diagnostic methods
RU2445915C1 (ru) Способ прогнозирования риска снижения уровня резистентности организма к острым респираторным заболеваниям у детей в возрасте 3-7 лет по индексу авидности секреторного иммуноглобулина а
JP2012526543A5 (enExample)
JP2008504551A5 (enExample)
WO2010005077A1 (ja) パーキンソン病の疾患関連たんぱく質およびその使用
JP2015068760A (ja) 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
JP2015503106A5 (enExample)
JP6436777B2 (ja) 精神関連疾患の検査方法および検査キット
CN117741143B (zh) Siglec-9蛋白及其特异性抗体在制备神经梅毒或神经损伤诊断产品中的应用
JP2020051911A (ja) 心不全マーカー
JP6613526B2 (ja) 膠芽腫の予測方法
TW202321697A (zh) 用於診斷輕度認知功能障礙的方法與套組